News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Law Firms Test AI Agents That Plan and Draft on Their Own
Harvey and other platforms are deploying autonomous AI agents in legal workflows, from document review to full contract generation. Lawyers remain essential—but their role is shifting to oversight and quality control.
Jylo Opens Strasbourg Office to Serve EU Legal Market
London-founded legal AI platform Jylo opens second office in Strasbourg, positioning itself near EU regulatory bodies. The move reflects client demand across Europe, with Germany emerging as a core market.
Patent Startup Stilta Raises $10.5M From A16Z, OpenAI Founders
Stilta, an AI patent litigation firm, closed $10.5M led by Andreessen Horowitz. The startup has signed Roche, Alfa Laval, and Maersk as customers since February launch.
Eudia and OpenAI team up on US government legal contracts
Legal AI firm Eudia expands its $1.25M Air Force deal into a broader partnership with OpenAI, co-building solutions for federal acquisition and legal teams. Here's what the partnership covers.
Lavern Open-Sources 67 Legal Agents in 155K-Line Codebase
Antti Innanen released Lavern as Apache 2.0 open source after failing to find a commercial home. The legal AI toolkit includes multi-agent debate, local privacy architecture, and modular components designed to be reused outside law.
Legal AI Reads Correctly but Points to Wrong Answer Across Borders
Legal AI produces fluent, terminology-perfect output that can still mislead lawyers on enforceability and remedies. The problem lives in training data, not prompts — and under time pressure, it passes review.
Intel's Legal Chief: AI Won't Replace Lawyers, Just Expose Low-Value Work
Joy Sherrod, Intel's Director of Discovery and Associate General Counsel, argues in-house attorneys need tech fluency but not a tech-first hiring approach. Here's how she's navigating AI adoption at scale.
Regeneron's melanoma combo fails to beat Keytruda in late-stage trial
Regeneron's fianlimab and Libtayo combo showed no significant advantage over Merck's Keytruda in a phase 3 melanoma study. The result erased billions in market value and upended analyst expectations.
Pharma leaders share summer reads—what CEOs learn from business memoir
Biopharma executives recommend books on leadership and decision-making. We unpack what pharma boards should actually take from these lessons.
India cancels NEET medical exam, June 21 retake under new security
India's education ministry cancelled the May 3 NEET-UG entrance exam after irregularities and will hold a retake June 21. Minister Pradhan ordered strict security protocols and coordination with state officials.
HCG opens ₹129 crore Bengaluru cancer center with robotic surgery
Indian oncology chain HCG launches 132-bed Hebbal facility with MRI-linac machines and five robotic operation theaters. The third center in Bangalore expands capacity as KKR-backed expansion continues.
Cell surface sugar patterns reveal early cancer signs in new imaging study
Max Planck Institute researchers mapped sugar structures on cell surfaces and found distinct patterns in cancer tissue. The technique could enable earlier disease detection.